Journals / Journal of the Turkish-German Gynecological Association / 2005 / Cilt: 6 - Sayı: 2

Östradiol hemihidrat ve noretisteron asetatın postmenopozal kadınlarda karotis ve renal arter kan akımına etkisi

Effect of daily estradiol hemihidrate and noresthisterone acetate on carotid and renal arterial blood flow in postmenopausal women

Pages
146–150
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Daily combined 2 mg estradiol and 1 mg norethisterone acetate use has no favourable short term effects on ca¬rotid and renal arterial perfusion that supply the two main end-organs, the brain and the kidneys.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine short term effects of daily combined 2 mg estradiol hemihidrate and 1 mg norethisterone acetate on internal carotid artery and renal artery in postmenopausal women.
📊
Key Findings & Data:Daily combined 2 mg estradiol hemihidrate and 1 mg norethisterone acetate were given for 6 months.
💡
Conclusion & Impact:Conclusion: Daily combined 2 mg estradiol and 1 mg norethisterone acetate use has no favourable short term effects on ca¬rotid and renal arterial perfusion that supply the two main end-organs, the brain and the kidneys.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To determine short term effects of daily combined 2 mg estradiol hemihidrate and 1 mg norethisterone acetate on internal carotid artery and renal artery in postmenopausal women. Materials and Methods: Fifty postmenopausal women who applied to our menopause outpatient clinic were recruited into the study. Daily combined 2 mg estradiol hemihidrate and 1 mg norethisterone acetate were given for 6 months. Internal ca¬rotid and renal artery pulsatility indices were assessed by color flow pulsed doppler. Paired t test was used for statistical analy¬sis. Results: There were no significant differences in weight, arterial blood pressure and pulsatility indices before and after tre¬atment (P>0.05). Pulsatility indices before and after treatment were 0.87±0.17 and 0.89±0.13 for right internal carotid ar¬tery and 0.84±0.12 and 0.86±0.11 for left internal carotid artery respectively. Pulsatility indices before and after treatment were 0.98±0.17 and 1.01±0.14 for right renal artery and 0.98±0.16 and 0.98±0.15 for left renal artery respectively. Conclusion: Daily combined 2 mg estradiol and 1 mg norethisterone acetate use has no favourable short term effects on ca¬rotid and renal arterial perfusion that supply the two main end-organs, the brain and the kidneys.

Özet

Amaç: Postmenopozal kadınlarda günlük kombine 2 mg estradiol hemihidrat ve 1 mg noretisteron asetat kullanımının in¬ternal karotis arter ve renal arter üzerine kısa dönemdeki etkilerinin incelenmesi. Materyal ve Metot: Menopoz polikliniğimize başvuran postmenopozal dönemdeki 50 kadın çalışmaya alındı. Günlük kom¬bine 2 mg estradiol hemihidrat ve 1 mg noretisteron asetat 6 ay boyunca uygulandı. Internal karotis ve renal arter pulsatili-te indeksleri 'color flow pulsed Doppler' ile incelendi. İstatistiksel incelemede 'Paired t' testi kullanıldı. Sonuçlar: Çalışma öncesi ve 6 aylık tedavi sonrası hastaların kilo, arter kan basıncı ve pulsatilite indeksleri arasında anlam¬lı fark saptanmadı (P>0.05). Internal karotis arter pulsatilite indeksleri sağ taraf için tedavi öncesi ve sonrasında sırası ile 0.87±0.17 ve 0.89±0.13; sol taraf için tedavi öncesi ve sonrasında sırası ile 0.84±0.12 ve 0.86±0.11 idi. Renal arter pulsatili¬te indeksleri sağ taraf için tedavi öncesi ve sonrasında sırasıyla 0.98±0.17 ve 1.01 ±0.14; sol taraf için tedavi öncesi ve sonra¬sında sırasıyla 0.98+0.16 and 0.98±0.15 idi. Tartışma: Postmenopozal dönemde günlük kombine 2 mg estradiol hemihidrat ve 1 mg noretisteron asetat kullanımının be¬yin ve böbrek gibi iki 'hedef-organ'ı besleyen karotis ve renal arter perfüzyonuna kısa dönemde olumlu etkisi yoktur.

🔖

Cite This Article

BAKSU, B., VAROLAN, A., DAVAS, İ., YAZGAN, A., AKYOL, A., YOLDEMİR, T. (2022). Östradiol hemihidrat ve noretisteron asetatın postmenopozal kadınlarda karotis ve renal arter kan akımına etkisi. Journal of the Turkish-German Gynecological Association, Cilt: 6 - Sayı: 2, 146–150. https://ajindex.com/articles/568042

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole Wilson PA. 17 b-estradiol attenuates acetylcholine- induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24-30
  2. Maas AH, Van Gilst WH, Verheught FW. Hormonal supplement therapy in women: effects on cardiovascular system. Ned Tijdschr Geneeskd 2001;145:65-9
  3. Simon T, Jaillon P. Hormone replacement therapy and cardiovascular risk in menopausal women. Arch Mai Couer Vaiss 2001;94:132-8
  4. Grimes DA. Prevention of cardiovascular disease in women: role of the obsterician-gynecologist. Am J Obstet Gynecol 1988;158:1662-8
  5. Stampfer MJ, Colditz GA, Willet WC, Manşon JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen treatment and cardiovascular disease. N Eng J Med 1991;325:756-62
  6. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal estrogen treatment and stroke: a prospective study. BMJ 1988;297:519-22
  7. Tikkanen MJ. Estrogens, progestins and lipid metabolism. Maturitas 1996;23:51-5
  8. Harman SM, Brinton EA, Clarkson T et al. Is the WHI relevant to HRT started in the perimenopause? Endocrine 2004;24:195-202
  9. Sitruk-Ware RL. Hormone therapy and the cardiovascular systems: the crutial role of progestins. Climacteric 2003;6 Suppl 3:21-8
  10. Iemolo F, Martiniuk A, Steinman DA, Spence JD. Sex differences in carotid plaque and stenosis. Stroke 2004;35:477-81 11. Mendelson ME, Karas RH. The protective effects of estrogen on the car¬ diovascular system. N Eng J Med 1999;340:1801-5
  11. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinic's Program Follow-up Study. Circulation 1987;75:1102-9
  12. Seyisoğlu H. Cardiovascular system in postmenopausal period. In: Ertüngealp E, Seyisoğlu H (editors). Menopause and Osteoporosis. Istanbul. National Menopause and Osteoporosis Society. 2000:96-104
  13. Pines A, Fisman EZ, Ayalon D, Drory Y, Averbuch M, Levo Y. Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women. Chest 1992; 102:1496-8
  14. Lau TK, Chung TK, Haines CJ. A preliminary study on the effect of the hormone replacement therapy on peripheral flow velocity in postmenopausal women. Maturitas 1997;26:53-6
  15. Colditz GA. The Nurses' Health Study: 20 year contribution to the und